New method detects Zika virus in blood transfusion
A project of the Pró-Sangue / Hemocentro Foundation of São Paulo, supported by the São Paulo State Foundation for Research Support (FAPESP), was able to develop a method that detects the presence of According to José Eduardo Levi, head of the Department of Molecular Biology of the Pró-Sangue Foundation and coordinator of the research, the idea is to use this method in the screening of blood bags that will be used in blood transfusions. pregnant women or intrauterine transfusions (ie, where the blood is transferred directly to the fetus).
"We thought it would not be a good idea, in these cases, to use blood at risk of having the virus. Our proposal was to do a test to be used in a small number of blood bags? 0.16% of the stock of the blood bank? intended for this target audience.We intend to begin to apply the test in the Blood Center of São Paulo shortly after Carnival ?, said the researcher to the FAPESP Agency
For the time being, two cases of blood transfusion transmission of the Zika virus were confirmed at the Hemocentro of the State University of Campinas (Unicamp), but none of the patients presented symptoms.The biggest fear is that the virus is passed for pregnant women through this contagion route, since there are great suspicions that this means of transmission may also lead to the development of microcephaly.
When a patient who had breast cancer could become pregnant ? The answer to this question is somewhat complex and of fundamental importance. Women who are thinking of becoming pregnant after breast cancer treatment should consult their doctor for advice about the current treatment they are having. For example, women are forbidden to become pregnant during chemotherapy and also during hormone therapy (which is usually done with a medication called tamoxifen in this age group) because these treatments are associated with poor baby training.
Vaccines produced in cell culture, considered safer and more potent, became available throughout the Brazilian public network beginning in 2003. Until 2001, immunization was produced in nervous tissues of infants (Fuenzalida & Palácios modified). The vaccine is optional and indicated for the risk groups.